Our top pick for
Acamar Partners Acquisition Corp is a shell companies business based in the US. Acamar Partners Acquisition shares (ACAM) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||$10.08 - $12.70|
|50-day moving average||$11.43|
|200-day moving average||$10.39|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.02|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Acamar Partners Acquisition stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Acamar Partners Acquisition's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Acamar Partners Acquisition's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 586x. In other words, Acamar Partners Acquisition shares trade at around 586x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
|Gross profit TTM||$0|
|Return on assets TTM||-0.37%|
|Return on equity TTM||0%|
|Market capitalisation||$469.8 million|
TTM: trailing 12 months
There are currently 327,038 Acamar Partners Acquisition shares held short by investors – that's known as Acamar Partners Acquisition's "short interest". This figure is 8.3% up from 301,855 last month.
There are a few different ways that this level of interest in shorting Acamar Partners Acquisition shares can be evaluated.
Acamar Partners Acquisition's "short interest ratio" (SIR) is the quantity of Acamar Partners Acquisition shares currently shorted divided by the average quantity of Acamar Partners Acquisition shares traded daily (recently around 1.6 million). Acamar Partners Acquisition's SIR currently stands at 0.21. In other words for every 100,000 Acamar Partners Acquisition shares traded daily on the market, roughly 210 shares are currently held short.
However Acamar Partners Acquisition's short interest can also be evaluated against the total number of Acamar Partners Acquisition shares, or, against the total number of tradable Acamar Partners Acquisition shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Acamar Partners Acquisition's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Acamar Partners Acquisition shares in existence, roughly 10 shares are currently held short) or 0.0107% of the tradable shares (for every 100,000 tradable Acamar Partners Acquisition shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Acamar Partners Acquisition.
Find out more about how you can short Acamar Partners Acquisition stock.
We're not expecting Acamar Partners Acquisition to pay a dividend over the next 12 months.
Acamar Partners Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the consumer and retail industries. The company was founded in 2018 and is based in Miami, Florida. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.